Viromed Medical AG (ETR:VME)
4.700
0.00 (0.00%)
At close: Oct 26, 2026
Viromed Medical AG Revenue
Viromed Medical AG had revenue of 2.55M EUR in the half year ending June 30, 2026. This brings the company's total for the last twelve months to 5.22M, up 115.74% year-over-year. In the year 2025, Viromed Medical AG had annual revenue of 5.09M with 352.27% growth. That makes Viromed Medical AG the 39,462nd largest company in the world by revenue and 539th in Germany.
Revenue (ttm)
5.22M
Revenue Growth
+115.74%
P/S Ratio
19.15
Revenue / Employee
306.79K
Employees
17
Market Cap
99.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.09M | 3.96M | 352.27% |
| Dec 31, 2024 | 1.12M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| MEDICLIN Aktiengesellschaft | 819.84M |
| FamiCord AG | 87.78M |
| LIMES Schlosskliniken AG | 56.72M |
| DocCheck AG | 56.65M |